Login / Signup

Recent Strategic Advances in CFTR Drug Discovery: An Overview.

Marco RusnatiPasqualina D'UrsiNicoletta PedemonteChiara UrbinatiRobert C FordElena CicheroMatteo UggeriAlessandro OrroPaola Fossa
Published in: International journal of molecular sciences (2020)
Cystic fibrosis transmembrane conductance regulator (CFTR)-rescuing drugs have already transformed cystic fibrosis (CF) from a fatal disease to a treatable chronic condition. However, new-generation drugs able to bind CFTR with higher specificity/affinity and to exert stronger therapeutic benefits and fewer side effects are still awaited. Computational methods and biosensors have become indispensable tools in the process of drug discovery for many important human pathologies. Instead, they have been used only piecemeal in CF so far, calling for their appropriate integration with well-tried CF biochemical and cell-based models to speed up the discovery of new CFTR-rescuing drugs. This review will give an overview of the available structures and computational models of CFTR and of the biosensors, biochemical and cell-based assays already used in CF-oriented studies. It will also give the reader some insights about how to integrate these tools as to improve the efficiency of the drug discovery process targeted to CFTR.
Keyphrases
  • cystic fibrosis
  • drug discovery
  • pseudomonas aeruginosa
  • lung function
  • single cell
  • high throughput
  • small molecule
  • mesenchymal stem cells
  • induced pluripotent stem cells
  • bone marrow
  • pluripotent stem cells